EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 2,158 press releases posted in the last 24 hours and 433,754 in the last 365 days.

Press Releases on May 11, 2023

2,307 Press Releases

Published on May 11, 2023 - 20:07 GMT

SANTA CLARA DE UCHUNYA PUCALLPA @Sudacaperu

Luis Miranda estuvo colaborando con Sudaca con informes sobre la problemática de la selva y el desarrollo de las comunidades. PUCALLPA, UCAYALI, PERU, May 11, 2023 /⁨EINPresswire.com⁩/ -- En los últimos meses Luis Miranda estuvo colaborando con Sudaca con …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...
Published on May 11, 2023 - 20:07 GMT

MONDAY DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Signature Bank Investors With Losses in Excess of $1 Million to ...

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Signature Bank (OTC: SBNY, SBNYP) between March 2, 2023 and March 12, 2023, both dates inclusive (the “Class Period …

Distribution channels: Consumer Goods, Law ...
Published on May 11, 2023 - 20:07 GMT

Getty Images Reports First Quarter 2023 Results

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the first quarter ended March 31, 2023. …

Distribution channels: Business & Economy, Media, Advertising & PR ...
Published on May 11, 2023 - 20:06 GMT

Albertsons Companies Voluntarily Recalls Oatmeal Raisin Cookies Sold at a Safeway Store in Duvall, Wash. Due to an Undeclared ...

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …

Distribution channels: Food & Beverage Industry
Published on May 11, 2023 - 20:05 GMT

ATA Creativity Global Reports First Quarter 2023 Financial Results

BEIJING, May 11, 2023 (GLOBE NEWSWIRE) -- ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today …

Distribution channels: Business & Economy, Technology ...
Published on May 11, 2023 - 20:05 GMT

Canterbury Park Holding Corporation Reports First Quarter Results

SHAKOPEE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation (“Canterbury” or the “Company”) (NASDAQ: CPHC), today reported financial results for the first quarter ended March 31, 2023. ($ in thousands, except per share data and …

Distribution channels: Amusement, Gaming & Casino, Business & Economy ...
Published on May 11, 2023 - 20:05 GMT

DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights

First patient dosed in global Phase 2b clinical trial of lead oral IL-17 inhibitor, DC-806, in moderate-to-severe psoriasis Topline data from Phase 1 clinical trial of second oral IL-17 inhibitor, DC-853, in healthy volunteers expected in 2H 2023 Strong …

Distribution channels: Business & Economy, Technology ...
Published on May 11, 2023 - 20:05 GMT

Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlights

- On Track to Report Initial Clinical Data from pheEDIT PKU Gene Editing Trial Mid-Year 2023 - - First Presentations of Preclinical Data with GTx-mAb Development Candidate HMI-104 for PNH, and Potential for Re-Dosing with AAVHSCs, at Upcoming ASGCT Meeting …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 11, 2023 - 20:05 GMT

23andMe to Report FY2023 Fourth Quarter and Full Year Financial Results

SOUTH SAN FRANCISCO, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report financial results for the fiscal year 2023 (FY2023) fourth …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on May 11, 2023 - 20:05 GMT

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023

PORTLAND, Maine, May 11, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Distribution channels: Business & Economy, Technology ...
Published on May 11, 2023 - 20:05 GMT

Rigetti Computing Reports First Quarter 2023 Results

BERKELEY, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the first quarter ended March 31, 2023. …

Distribution channels: Business & Economy, IT Industry ...
Published on May 11, 2023 - 20:05 GMT

Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update

Enrollment continues in Phase 1 dose escalation study for VIP236, a first-in-class αvβ3 small molecule drug conjugate (SMDC) for the treatment of solid tumors IND filing for VIP943, a next-generation antibody-drug conjugate (ADC), for treatment of CD123+ …

Distribution channels: Business & Economy, Technology ...
Published on May 11, 2023 - 20:05 GMT

Spero Therapeutics Announces First Quarter 2023 Operating Results and Provides a Business Update

Phase 2 trial of SPR720 in nontuberculous mycobacterial pulmonary disease (NTM-PD) on track for top line data readout in 1H 2024 Update on status of Special Protocol Assessment agreement for tebipenem HBr program expected mid-year 2023; initiation of Phase …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 11, 2023 - 20:05 GMT

180 Degree Capital Corp. Notes $6.52 Net Asset Value per Share as of March 31, 2023 and $5 Million Reauthorized Share Repurchase ...

MONTCLAIR, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today reported its financial results as of March 31, 2023, and additional developments from the second quarter of 2023. The Company also …

Distribution channels: Banking, Finance & Investment Industry ...
Published on May 11, 2023 - 20:05 GMT

Post Holdings Partnering Corporation To Redeem its Public Shares and Will Not Consummate a Partnering Transaction

ST. LOUIS, May 11, 2023 (GLOBE NEWSWIRE) -- Post Holdings Partnering Corporation (NYSE: PSPC) (the “Company”) today announced that its board of directors (the “Board”) has decided to redeem all of its outstanding shares of Series A common stock, par value …

Distribution channels: Banking, Finance & Investment Industry, Companies ...
Published on May 11, 2023 - 20:05 GMT

Rain Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Progress

– Quarter-end cash position of $110 million provides runway to complete all ongoing and planned clinical trials of milademetan, including the Phase 3 MANTRA trial in liposarcoma, Phase 2 MANTRA-2 basket trial, and planned Phase 1/2 MANTRA-4 basket trial – …

Distribution channels: Business & Economy ...
Published on May 11, 2023 - 20:05 GMT

Histogen Reports First Quarter 2023 Results and Provides Business Update

Received FDA Clearance of IND Application for Emricasan for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Emricasan Treatment has Therapeutic Effect Against Bacterial Skin Infection in Mice Signed Exclusive Intellectual …

Distribution channels: Business & Economy, Technology ...
Published on May 11, 2023 - 20:05 GMT

Kinnate Biopharma Inc. Reports First Quarter 2023 Financial Results and Recent Corporate Updates

Presented positive monotherapy dose escalation data for exarafenib, an investigational pan-RAF inhibitor, at the 2023 AACR Annual Meeting Provided update on ongoing exarafenib monotherapy dose expansion; data-informed strategy prioritizes enrollment in …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 11, 2023 - 20:05 GMT

Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results

-- Company to host call at 4:30pm today -- NEWTOWN, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 11, 2023 - 20:05 GMT

Bolt Biotherapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

Comprehensive BDC-1001 clinical safety and efficacy data as a single agent and in combination with nivolumab, including RP2D, to be presented at ASCO 2023 BDC-1001 Phase 2 program expected to initiate in 2023 in HER2+ colorectal, endometrial, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Previous 12 13 14 15 16 17 18 19 20 21 22 Next

Previous Day 2023 Calendar Next Day